Authors’ responses to Letter to the Editor regarding ‘Early digoxin-specific antibody fragments to treat patients at risk of life-threatening toxicity’: Clinical Toxicology: Vol 52, No 9

653

Views

CrossRef citations to date

Altmetric

"Authors’ responses to Letter to the Editor regarding ‘Early digoxin-specific antibody fragments to treat patients at risk of life-threatening toxicity’." Clinical Toxicology, 52(9), p. 987

Declaration of interest

The authors report no declarations of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Authors’ responses to Letter to the Editor regarding ‘Early digoxin-specific antibody fragments to treat patients at risk of life-threatening toxicity’

Information for

Open access

Opportunities

Help and information

Authors’ responses to Letter to the Editor regarding ‘Early digoxin-specific antibody fragments to treat patients at risk of life-threatening toxicity’

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature